ATP-Sensitive Potassium Channels and Myocardial Ischemia

  • Canwen Jiang
  • Philip A. Poole-Wilson
  • Seibu Mochizuki
Part of the Progress in Experimental Cardiology book series (PREC, volume 1)


The KATP channel plays an important role in mediating a variety of pathophysiological responses during myocardium ischemia and exhibits cardioprotective effects. As a consequence of the recent cloning of the subunits of the KATP, channel, efforts are being made to understand its properties, regulation, and physiological role in coupling the metabolic state of a cell to excitability. Advances are anticipated in the understanding of the cellular and molecular mechanisms underlying the role of the KATP channel during myocardial ischemia. The modulators of the KATP channel are of great value as therapeutic agents for the treatment of ischemic heart disease. Newly identified tissue-selective KATP channel openers may result in important advances in the treatment of cardiovascular disease.


Vascular Smooth Muscle Cell Cardiac Myocytes KATp Channel Ischemic Precondition Action Potential Duration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ashcroft FM, 1988. Adenosine 5′-triphosphate-sensitive potassium channels. Annu Rev Neurosci 11:97–118.PubMedCrossRefGoogle Scholar
  2. 2.
    Moma A. 1983. ATP-regulated K+ channels in cardiac muscle. Nature 305:147–148.CrossRefGoogle Scholar
  3. 3.
    Noma A, Shibasaki T. 1985. Membrane current through adenosine-triphosphate-regulated potassium channels in guinea-pig ventricular cells. J Physiol 363:463–480.PubMedGoogle Scholar
  4. 4.
    Nichols CG, Lederer WJ. 1990. The regulation of ATP-sensitive K+ channel activity in intact and pemeabilized rat ventricular myocytes. J Physiol 423:91–110.PubMedGoogle Scholar
  5. 5.
    Standen NB, Quayle JM, Davies NW, Brayden JE, Huang Y, Nelson MT. 1989. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science 245:177–180.PubMedCrossRefGoogle Scholar
  6. 6.
    Silberberg SD, Van Breemen C. 1990. An ATP, calcium and voltage sensitive potassium channel in porcine coronary artery smooth muscle cells. Biochem Biophys Res Commun 172:517–522.PubMedCrossRefGoogle Scholar
  7. 7.
    Nichols CG, Lederer WJ. 1991. Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol 261:H1675–H1686.PubMedGoogle Scholar
  8. 8.
    Loptin AN, Makhina EN, Nichols CG. 1994. Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature 372:366–369.CrossRefGoogle Scholar
  9. 9.
    Sturgess NC, Ashford ML, Carrington CA, Hales CN. 1986. Single channel recordings of potassium currents in an insulin-secreting cell line. J Endocrinol 109:201–207.PubMedGoogle Scholar
  10. 10.
    Kakei M, Noma A, Shibasaki T. 1985. Properties of adenosine-triphosphate-regulated potassium channels in guinea-pig ventricular cells. J Physiol 363:441–462.PubMedGoogle Scholar
  11. 11.
    Rorsman P, Trube G. 1990. Biophysics and physiology of ATP-regulated K+ channels. In Cook N (ed), Potassium Channels. Chichester, UK: Ellis Horwood Limited, pp. 96–116.Google Scholar
  12. 12.
    Tung RT, Kurachi Y. 1991. On the mechanism of nucleotide diphosphate activation of the ATP-sensitive K+ channel in ventricular cell of guinea-pig. J Physiol 437:239–256.PubMedGoogle Scholar
  13. 13.
    Findlay I, Dunne MJ. 1986, ATP maintains ATP-inhibited K+ channels in an operational state. Pflugers Arch 407:238–240.PubMedCrossRefGoogle Scholar
  14. 14.
    Kakei M, Kelly RP, Ashcroft: SJ, Ashcroft: FM. 1986. The ATP-sensitivity of K+ channels in rat pancreatic B-cells is modulated by ADP. FEBS Lett 208:63–66.PubMedCrossRefGoogle Scholar
  15. 15.
    Light P. 1996. Regulation of ATP-sensitive potassium channels by phosphorylation. Biochim Biophys Acta 1286:65–73.PubMedGoogle Scholar
  16. 16.
    Kakei M, Noma A. 1984. Adenosine-5′-triphosphate-sensitive single potassium channel in the atrioventricular node cell of the rabbit heart. J Physiol 352:265–284.PubMedGoogle Scholar
  17. 17.
    Nelson MT, Huang Y, Brayden JE, Hescheler J, Standen NB. 1990. Arterial dilations in response to calcitonin gene-related peptide involve activation of K+ channels. Nature 344:770–773.PubMedCrossRefGoogle Scholar
  18. 18.
    Weston AH, Edwards G. 1992. Recent progress in potassium channel opener pharmacology. Biochem Pharmacol 43:47–54.PubMedCrossRefGoogle Scholar
  19. 19.
    Jiang C, Mochizuki S, Poole-Wilson PA, Harding SE, Macleod KT. 1994. Effect of lemakalim on action potentials, intracellular calcium, and contraction in guinea pig and human cardiac myocytes. Cardiovasc Res 28:851–857.PubMedGoogle Scholar
  20. 20.
    Ho K, Nichols CG, Lederer WJ, Lytton J, Vassiley PM, Kanazirska MV, Hebert SC. 1993. Cloning and expression of an inwardly rectifying ATP-regulated potassium channel. Nature 362:31–38.PubMedCrossRefGoogle Scholar
  21. 21.
    Nichols CG, Makhina EN, Pearson WL, Sha Q, Lopatin AN. 1996. Inward rectification and implications for cardiac excitability. Circ Res 78:1–7.PubMedGoogle Scholar
  22. 22.
    Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP IV, Boyd AE III, Gonzalez G, HerreraSosa H, Nguy K, Nelson DA. 1995. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 268:423–426.PubMedCrossRefGoogle Scholar
  23. 23.
    Inagaki N, Gonoi T, Clement JP IV, Namba N, Inazawa J, Gonzalez G, Aguilar-Bryan L, Seino S, Bryan J. 1995. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 270:1166–1170.PubMedCrossRefGoogle Scholar
  24. 24.
    Faivre JF, Findlay I. 1990. Action potential duration and activation of ATP-sensitive potassium current in isolated guinea-pig ventricular myocytes. Biochim Biophys Acta 1029:167–172.PubMedCrossRefGoogle Scholar
  25. 25.
    Findlay I. 1988. Effects of ADP upon the ATP-sensitive K+ channel in rat ventricular myocytes. J Memb Biol 101:83–92.CrossRefGoogle Scholar
  26. 26.
    Nichols CG, Ripoll C, Lederer WJ. 1991. ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction. Circ Rec 68:280–287.Google Scholar
  27. 27.
    Clapp LW, Curney AM. 1992. ATP-sensitive K+ channels regulate resting potential of pulmonary arterial smooth muscle cells. Am J Physiol 262:W916–H920.Google Scholar
  28. 28.
    De Weille JR, Fosset M, Mourre C, Schmid-Antomarchi H, Bernardi H, Lazdunski M. 1989. Pharmacology and regulation of ATP-sensitive K+ channels. Pflugers Arch 414(Suppl 1):S80–S87.PubMedCrossRefGoogle Scholar
  29. 29.
    Jiang C. 1993. The Regulatory Role of Adenosine 5′-Triphosphate-Sensitive Potassium Channels in Mammalian Cardiac Muscle and Coronary Smooth Muscle. Ph.D, thesis, Imperial College of Science, Technology, and Medicine, School of Medicine at the National Heart and Lung Institute, University of London, 1993.Google Scholar
  30. 30.
    Jiang C, Poole-Wilson PA, Collins P. 1991. Comparison of rabbit coronary arterial relaxation induced by acetylcholine and lemakalim: activation of ATP sensitive potassium channels. Cardiovasc Res 25:930–935.PubMedGoogle Scholar
  31. 31.
    Miyoshi Y, Nakaya Y, Wakatsuki T, Nakaya S, Fujino K, Saito K, Inoue I. 1992. Endothelin blocks ATP-sensitive K+ channels and depolarizes smooth muscle cells of porcine coronary artery. Circ Res 70:612–615.PubMedGoogle Scholar
  32. 32.
    Weiss J, Hiltbrand B. 1985. Functional compartmentation of glycolytic versus oxidative metabolism in isolated rabbit heart. J Clin Invest 75:436–447.PubMedGoogle Scholar
  33. 33.
    Elliott AC, Smith GL, Allen PG. 1989. Simultaneous measurements of action potential duration and intracellular ATP in isolated ferret hearts exposed to cyanide. Circ Res 64:583–591.PubMedGoogle Scholar
  34. 34.
    Keung EC, Li Q. 1991. Lactate activates ATP-sensitive potassium channels in guinea pig ventricular myocytes. J Clin Invest 88:1772–1777.PubMedGoogle Scholar
  35. 35.
    Jiang C, Collins P. 1994. Inhibition of hypoxia-induced relaxation of rabbit isolated coronary arteries by NG-monomethyl-L-arginine but not glibenclamide. Br J Pharmacol 111:711–716.PubMedGoogle Scholar
  36. 36.
    Jiang C, Crake T, Poole-Wilson PA. 1991. Inhibition by barium and glibenclamide of the net loss of 86Rb+ from rabbit myocardium during hypoxia. Cardiovasc Res 25:414–420.PubMedCrossRefGoogle Scholar
  37. 37.
    Escande D, Henry P. 1993. Potassium channels as pharmacological targets in cardiovascular medicine. Eur Heart J 14(Suppl B):2–9.PubMedGoogle Scholar
  38. 38.
    Auchampach JA, Maruyama M, Cavero I, Gross GJ. 1991, The new K+ channel opener Aprikalim (RP 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes. J Pharmacol Exp Ther 259:961–967.PubMedGoogle Scholar
  39. 39.
    Edwards G, Weston AH. 1990. Potassium channel openers and vascular smooth muscle relaxation. Pharmacol Ther 48:237–258.PubMedCrossRefGoogle Scholar
  40. 40.
    Daut J, Maier-Rudolph W, Beckerath N, Mehrke G, Gunter K, Goedel-Meinen L. 1990. Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 247:1341–1342.PubMedCrossRefGoogle Scholar
  41. 41.
    Kirsch GE, Codina J, Birnbaumer L, Brown AM. 1990. Coupling of ATP-sensitive K+ channels to A1 receptors by G proteins in rat ventricular myocytes. Am J Physiol 259:H820–H826.PubMedGoogle Scholar
  42. 42.
    Belloni FL, Hintze TH. 1991. Glibenclamide attenuates adenosine-induced bradycardia and coronary vasodilatation. Am J Physiol 261:H720–H727.PubMedGoogle Scholar
  43. 43.
    Wei HM, Kang YH, Merrill GF. 1989. Canine coronary vasodepressor responses to hypoxia are abolished by 8-phenyltheophylline, Am J Physiol 257:H1043–H1048.PubMedGoogle Scholar
  44. 44.
    Venkatesh N, Lamp ST, Weiss JN. 1991. Sulfonylureas, ATP-sensitive K+ channels, and cellular K+ loss during hypoxia, ischemia, and metabolic inhibition in mammalian ventricle. Circ Res 69:623–637.PubMedGoogle Scholar
  45. 45.
    Kantor PF, Coetzee WA, Cameliet EE, Dennis SC, Opie LH. 1990. Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulonylurea. Circ Res 66:478–485.PubMedGoogle Scholar
  46. 46.
    Cole WC, McPherson CD, Sontag D. 1991 ATP regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ Res 69:571–581.PubMedGoogle Scholar
  47. 47.
    Adams D, Crome R, Lad N, Manning AS, Mackenzie I. 1990. Failure of the ATP-dependent K+ channel inhibitor, glibenclamide, to reduce reperfusion-induced or ischemic arrhythmias in rat hearts. Br J Pharmacol 100(Suppl):438p.Google Scholar
  48. 48.
    Curtis MJ, Walker MJA. 1986. The mechanism of action of the optical enantiomers of verapamil against ischemia-induced arrhythmias in the conscious rat. Br J Pharmacol 89:137–147.PubMedGoogle Scholar
  49. 49.
    Wilde AAM. 1993. Role of ATP-sensitive K+ channel current in ischemic arrhythmias. Cardiovasc Drugs Ther 7:521–526.PubMedCrossRefGoogle Scholar
  50. 50.
    Murry CE, Jennings RB, Reimer U. 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124–1136.PubMedGoogle Scholar
  51. 51.
    Liu Y, Ytrehus K, Downey JM. 1994. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 26:661–668.PubMedCrossRefGoogle Scholar
  52. 52.
    Gross GJ. 1995. ATP-sensitive potassium channels and myocardial preconditioning. Basic Res Cardiol 90:85–88.PubMedCrossRefGoogle Scholar
  53. 53.
    Auchampach JA, Grover GJ, Gross GJ. 1992. Blockade of ischemic preconditioning in dogs by the novel ATP-dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res 26:1054–1062.PubMedCrossRefGoogle Scholar
  54. 54.
    Tomai F, Crea F, Caspardone A, Versaci F, Depaulis R, Penta de Peppo A, Chiaririe L, Gioffre’ PA. 1994. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 90:700–705.PubMedGoogle Scholar
  55. 55.
    Atwal KS. 1994. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers. J Cardiovasc Pharmacol 24:S12–S17.PubMedCrossRefGoogle Scholar
  56. 56.
    Knight C, Purcell H, Fox K. 1995. Potassium channel openers: clinical application in ischemic heart disease—overview of clinical efficacy of nicorandil. Cardiovasc Drugs Ther 9:229–236.PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • Canwen Jiang
    • 1
  • Philip A. Poole-Wilson
    • 2
  • Seibu Mochizuki
    • 3
  1. 1.Genzyme CorporationUSA
  2. 2.Imperial College School of Medicine at National Heart and Lung InstituteUK
  3. 3.Jikei University School of MedicineJapan

Personalised recommendations